Scott Koenig
CIK 1587514 · President and CEO · last filed 2026-05-20
Scott Koenig is a President and CEO who has filed 50 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for MGNX, was dated May 20, 2026. Current disclosed insider exposure totals $5.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.13M
3
50
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGNX | President and CEO | 1,294,720 | $3.96 | $5.13M | $0 | 28 | 2026-05-20 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 36,750 | $15.70 | $577.0K | $0 | 11 | 2024-05-01 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 0 | $0.39 | $0 | $0 | 11 | 2022-12-01 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2026-02-17 | MGNX | Exer (M) | +21,165 | $0 | EDGAR |
| 2026-02-10 | MGNX | Exer (M) | +15,831 | $0 | EDGAR |
| 2025-08-15 | MGNX | Exer (M) | +52,829 | $0 | EDGAR |
| 2025-02-19 | MGNX | Exer (M) | +42,329 | $0 | EDGAR |
| 2025-02-11 | MGNX | Mixed | +31,673 | $0 | EDGAR |
| 2024-10-09 | MGNX | Gift (G) | — | $0 | EDGAR |
| 2024-09-25 | MGNX | Gift (G) | — | $0 | EDGAR |
| 2024-05-01 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | MGNX | Mixed | +27,992 | -$249.7K | EDGAR |